Dr. BUTOLO ANDRA CATALINA

Dr. BUTOLO ANDRA CATALINA


Dr. BUTOLO ANDRA CATALINA | Oncologie

Medic specialist Oncologie Medicala

Competente:

  • Ultrasonografie generala

Experienta Profesionala

25 aprilie 2016 – present SC MNT HEALTHCARE EUROPE SRL Neolife Medical Center

Diagnostic si terapie oncologica medicala, screening, preventie,  consultatii in ambulatoriu, consultatii si asistenta de specialitate pentru pacientii internati – spitalizare de zi, ingrijiri paleative. Prezentari de caz ; redactare articole de specialitate.

 

1 ianuarie 2011 - 31 decembrie 2015 Medic Rezident Oncologie Medicala

Diagnostic si terapie oncologica medicala, screening, preventie, consultatii in ambulatoriu, consultatii si asistenta de specialitate pentru pacientii internati, ingrijiri paleative, consulturi interdisciplinare.

 

PROIECTE DE CERCETARE

1. GWCA0962 - A Double Blind, Randomized, Placebocontrolled, Parallel Group Study of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy, EUDRACT number: 2009-016065-29 –SubInvestigator– 2012-2015. 23.

2. GWCA0999 - A Multicenter, Non-comparative, Open-label, Extension Study to assess the long term safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Cancer Related Pain, EUDRACT number: 2010-022905-17 – SubInvestigator – 2012-2015.

3. GWCA1103 - A Two Part, Placebo-controlled, Study of Sativex® Oromucosal Spray (Sativex®, Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients with Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chornic Opioid Therapy, EUDRACT number: 2009-016529-32– SubInvestigator - 2014–2015.

4. A multicenter, randomised, double-blind, placebo-controlled Phase IIB Efficacy Study of Vx-001, a peptide based cancer vaccine aimed to maintain disease control after first line treatment in HLA A*0201 positive patients with TERT positive stage IV or recurrent stage I-III NSCLC. – 2015

 

LUCRARI STIINTIFICE, ARTICOLE

1. Difficulties in Therapeutical Approach of Craniopagus Conjoined Twins - Published in: Asian Journal of Neurosurgery - AJNS; Volume 3, Number 1, August 2009, Japan

2. “Gemeni uniti cranioencefalopagus” – CoAutor CGherghina I, Ciurea V, Anca AI, Iusan Mirela, Brezan F, Ciomartan T, Cinteza E, Matei D, Petrescu O, Oprea O, Dobre V, Butolo AC– in Antropologia si orizonturile ei, colectia Zilele Reiner, Ed. Niculescu, Bucuresti, 2010, pag 129 - 143

3. Lucrare de diploma – Insuficienta cardiaca la sugar si copil – studiu clinic pe 5 ani, Bucuresti, Septembrie 2010

4. Tratamentul concomitent radio-chimioterapic in cancerele ORL, -prim autor-Cornelia Nitipir, Xenia Bacinschi, StefanelVlad ,Manuela Barna,Simona Tulfan, Ana-Maria Tebeica, IonCristian Iaciu, Andra Butolo, Maria Barbu, Irina Radu,Conferinta Aniversara 75 de ani de la Infiintarea Spitalului Universitar de Urgenta Elias, 8 noiembrie 2013, Bucuresti

5. Metastases to the breast – differential diagnosis from primary breast carcinoma: case report”- Co-autor- Cornelia Nitipir, Bogdan Popescu, Andra Cătălina Butolo, Cristian Iaciu, Alexandru Opriță, Răzvan Costin, Irina Radu, Maria Alexandra Barbu- Paliatia, Journal of Palliative Care, Vol 8, No 3, July 2015, ISSN 1844 – 7058, BDI(EBSCO’s databaseproducts, SCIPIO)

6. Metastatic breast cancer management: a 5 cases Quality of Life analysis, -Co-autor- Cornelia Nitipir, Andra Cătălina Butolo, Cristian Iaciu, Alexandru Opriță, Bogdan Popescu, Irina Radu, Răzvan Costin, Maria Alexandra Barbu- Paliatia,Journal of Palliative Care, Vol 8, No 3, July 2015, ISSN 1844 –7058, BDI(EBSCO’s databaseproducts, SCIPIO)

Solicita o programare